References
1. Pritz T, Weinberger B, Grubeck-Loebenstein B. The aging bone marrow and its impact on immune responses in old age. Immunol Lett 2014;162 :310-5.
2. Pangrazzi L, Meryk A, Naismith E, et al. ”Inflamm-aging” influences immune cell survival factors in human bone marrow. Eur J Immunol 2017; 47 :481-92.
3. Pawelec G. Hallmarks of human ”immunosenescence”: adaptation or dysregulation? Immun Ageing 2012; 9 :15.
4. Peters A, Delhey K, Nakagawa S, et al. Immunosenescence in wild animals: meta-analysis and outlook. Ecol Lett 2019;22 :1709-22.
5. Yao WL, Wen Q, Zhao HY, et al. Different subsets of haematopoietic cells and immune cells in bone marrow between young and older donors. Clin Exp Immunol 2021; 203 :137-49.
6. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A 2011; 108 :20012-7.
7. Lynch HE, Goldberg GL, Chidgey A, et al. Thymic involution and immune reconstitution. Trends Immunol 2009; 30 :366-73.
8. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 1996; 17 :267-72.
9. Riether C, Schürch CM, Ochsenbein AF. Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ 2015;22 :187-98.
10. Naserian S, Abdelgawad ME, Afshar Bakshloo M, et al. The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect. Cell Commun Signal 2020;18 :94.
11. Crane GM, Jeffery E, Morrison SJ. Adult haematopoietic stem cell niches. Nat Rev Immunol 2017; 17 :573-90.
12. Poulos MG, Ramalingam P, Gutkin MC, et al. Endothelial transplantation rejuvenates aged hematopoietic stem cell function. J Clin Invest 2017; 127 :4163-78.
13. Hooper AT, Butler JM, Nolan DJ, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009; 4 :263-74.
14. Razakandrainibe R, Pelleau S, Grau GE, et al. Antigen presentation by endothelial cells: what role in the pathophysiology of malaria? Trends Parasitol 2012; 28 :151-60.
15. Lim WC, Olding M, Healy E, et al. Human Endothelial Cells Modulate CD4(+) T Cell Populations and Enhance Regulatory T Cell Suppressive Capacity. Front Immunol 2018; 9 :565.
16. Khayyamian S, Hutloff A, Buchner K, et al. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A 2002;99 :6198-203.
17. Liu J, Jiang M, Ma Z, et al. TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro. J Immunol 2013; 191 :6178-90.
18. Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun 2015;21 :827-46.
19. Hancock WW, Sayegh MH, Zheng XG, et al. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A 1996;93 :13967-72.
20. Lozanoska-Ochser B, Klein NJ, Huang GC, et al. Expression of CD86 on human islet endothelial cells facilitates T cell adhesion and migration. J Immunol 2008; 181 :6109-16.
21. Diehl L, Schurich A, Grochtmann R, et al. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 2008; 47 :296-305.
22. Limmer A, Ohl J, Kurts C, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000;6 :1348-54.
23. Cao XN, Kong Y, Song Y, et al. Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant. Br J Haematol 2018; 182 :870-86.
24. Kong Y, Cao XN, Zhang XH, et al. Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients. Blood 2018; 131 :1219-33.
25. Kong Y, Shi MM, Zhang YY, et al. N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation. Am J Hematol 2018; 93 :931-42.
26. Kong Y, Wang Y, Zhang YY, et al. Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation. Blood Adv 2019;3 :1303-17.
27. Lyu ZS, Cao XN, Wen Q, et al. Autophagy in endothelial cells regulates their haematopoiesis-supporting ability. EBioMedicine 2020; 53 :102677.
28. Kong Y, Wang YT, Cao XN, et al. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation. J Transl Med 2017; 15 :57.
29. Song Y, Wang YT, Huang XJ, et al. Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia.Ann Hematol 2016; 95 :959-65.
30. Wang YT, Kong Y, Song Y, et al. Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016;22 :1376-82.
31. Song Y, Shi MM, Zhang YY, et al. Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2017;23 :906-12.
32. Kong Y, Wu YL, Song Y, et al. Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL. J Transl Med 2017; 15 :184.
33. Kusumbe AP, Ramasamy SK, Itkin T, et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature 2016;532 :380-4.
34. Heiss C, Keymel S, Niesler U, et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45 :1441-8.
35. Rose ML. Endothelial cells as antigen-presenting cells: role in human transplant rejection. Cell Mol Life Sci 1998;54 :965-78.
36. Dunzendorfer S, Lee HK, Soldau K, et al. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. Faseb j 2004;18 :1117-9.
37. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12 :443-58.
38. Chang YJ, Zhao XY, Huang XJ. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease. Front Immunol 2018; 9 :3041.
39. Holtan SG, Pasquini M, Weisdorf DJ. Acute graft-versus-host disease: a bench-to-bedside update. Blood 2014; 124 :363-73.
40. Zeiser R, Socie G, Blazar BR. Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation. Br J Haematol 2016;175 :191-207.
41. Ferrara JLM, Levine JE, Reddy P, et al. Graft-versus-host disease. The Lancet 2009; 373 :1550-61.
42. Wang Y, Chang YJ, Xu LP, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood 2014; 124 :843-50.
43. Chang YJ, Luznik L, Fuchs EJ, et al. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? J Hematol Oncol 2016; 9 :35.
44. Mir E, Palomo M, Rovira M, et al. Endothelial damage is aggravated in acute GvHD and could predict its development. Bone Marrow Transplant 2017; 52 :1317-25.